GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine, a sequence first isolated from human plasma and later shown to form a stable coordination complex with copper(II) ions. The overview article what is GHK-Cu covers where the peptide comes from and the broad categories of research it appears in. This article goes further into three specific bodies of published work: the copper coordination chemistry that gives the complex its particular binding behavior, the gene-expression array datasets generated by Loren Pickart's research group, and the fibroblast culture and wound-model studies that measured collagen and extracellular matrix effects directly.
| Attribute | Detail |
|---|---|
| Core sequence | Glycyl-L-histidyl-L-lysine (Gly-His-Lys), a naturally occurring tripeptide |
| Metal ligand | Copper(II), coordinated primarily through the histidine imidazole and terminal amine groups |
| What gene-array studies measured | Changes in expression across large panels of genes linked to collagen, matrix remodeling, and antioxidant pathways in cultured human cells |
| What fibroblast studies measured | Collagen synthesis rates and matrix protein output in cultured dermal fibroblasts exposed to the tripeptide-copper complex |
| What wound-model studies measured | Glycosaminoglycan and small proteoglycan expression during the wound-healing time course in animal and cell models |
| Form supplied | Lyophilized powder, research use only |
How does GHK-Cu bind and release copper?
The tripeptide's affinity for copper(II) is high relative to many small biological ligands, which is part of why the complex was proposed as a physiological copper transport and delivery vehicle rather than an inert carrier. The histidine side chain's imidazole nitrogen is the principal coordinating group, working alongside the peptide's terminal amine and backbone nitrogens to form a square-planar or near-square-planar arrangement around the copper ion. Because this coordination is reversible rather than fixed, the complex can hand copper off to other cellular ligands and enzymes under the right conditions, which researchers have used to argue that GHK-Cu functions in cell and tissue models as a copper-exchange intermediate rather than simply as a static chelate. This binding behavior is the mechanistic starting point for essentially all of the downstream cell-culture and gene-expression work described below, since many of the enzymes affected in these studies are themselves copper-dependent, including lysyl oxidase, which cross-links collagen and elastin.
What did the Pickart gene-expression array studies measure?
Pickart and colleagues used large-scale gene-expression arrays to compare cultured human cells treated with GHK or GHK-Cu against untreated controls, looking at which genes shifted up or down across thousands of probes at once rather than testing one pathway at a time. In skin-focused work, this approach identified shifts in gene clusters connected to collagen production, antioxidant enzyme systems, and markers associated with a more youthful gene-expression profile in treated dermal cell cultures (Pickart et al., 2015). A separate array study extended this method to genes relevant to nervous system function, reporting changes in expression across genes linked to neurogenesis, synaptic signaling, and markers examined in models of cognitive decline (Pickart, 2017). Because array studies like these measure correlation across many genes simultaneously rather than a single causal pathway, the more recent review work has tried to organize the resulting gene lists into functional categories, such as collagen and matrix genes, antioxidant genes, and anti-inflammatory signaling genes, to make the dataset easier to interpret against the earlier, narrower fibroblast and wound-healing literature (Pickart and Margolina, 2018).
What have fibroblast culture studies measured for collagen synthesis?
The foundational fibroblast work in this area came from a French collagen-biochemistry group that tested the tripeptide-copper complex directly on cultured skin fibroblasts and measured collagen synthesis output using biochemical assays rather than gene arrays. That study reported that fibroblasts exposed to the glycyl-L-histidyl-L-lysine-copper complex synthesized collagen at a higher rate than untreated control cultures, and the effect held across a defined concentration range tested in vitro (Maquart et al., 1988). This paper predates the gene-array era by nearly three decades, and it is one of the reasons GHK-Cu research is often described as having converged from two directions: the older fibroblast biochemistry showing a functional effect on collagen output, and the newer gene-expression work trying to explain the transcriptional changes behind that effect.
What have wound-model studies measured?
Wound-model work has generally used a different set of readouts than the fibroblast collagen assays, focusing on the extracellular matrix components that accumulate during tissue repair rather than collagen alone. One study using an experimental wound model measured glycosaminoglycan and small proteoglycan expression over the course of healing and reported that the tripeptide-copper complex modulated the levels of specific matrix components, including decorin, at defined points in the wound-healing time course relative to untreated wounds (Siméon et al., 2000). This kind of measurement matters for interpreting the gene-array data, because glycosaminoglycans and proteoglycans are downstream products of several of the gene clusters flagged in the array studies, giving researchers a biochemical checkpoint to compare against the transcriptional signal. A broader review of the tissue-remodeling literature has tried to connect these wound-model findings back to the peptide's proposed role in signaling tissue repair and remodeling more generally, treating collagen synthesis and matrix component changes as two related but separately measured outputs of the same underlying copper-dependent mechanism (Pickart, 2008).
How does this body of work fit into broader peptide research categories?
GHK-Cu's gene-expression and matrix-biology literature sits alongside other short regulatory peptides studied for tissue-specific signaling effects, though the mechanisms are not interchangeable; background on a structurally distinct family of short peptides studied in organ-specific research contexts is covered in bioregulator peptides explained. Researchers comparing across these categories generally treat gene-array data as hypothesis-generating rather than as a final answer, which is why the fibroblast and wound-model studies described above remain the more direct functional evidence in this specific line of research.
Handling notes
GHK-Cu is supplied as a lyophilized powder for laboratory research. As with any copper-containing peptide complex, oxidation and copper dissociation are both time- and storage-dependent, so cold storage and prompt use after reconstitution matter for maintaining assay consistency; see peptide half-life explained for general background on why storage conditions affect a given research timeline. Confirm identity and purity against the lot-specific certificate of analysis before use in an assay. Lot-specific specs for research-grade GHK-Cu are posted on our GHK-Cu lot page.
Frequently asked questions
Is GHK-Cu the same thing as GHK?
No. GHK is the uncomplexed tripeptide. GHK-Cu refers specifically to the tripeptide bound to a copper(II) ion. Some published studies test the free peptide, others test the copper complex, and the two are not always directly comparable.
What kind of cells have been used in this research?
Cultured human dermal fibroblasts are the most common cell model in the collagen-synthesis literature. Gene-expression array studies have used broader panels of cultured human cells, and wound-model studies have combined cell-level matrix measurements with in vivo healing time courses.
Does a gene-expression change mean a functional effect was proven?
Not on its own. Gene-array studies show correlated shifts in expression across many genes at once, which is why researchers pair that data with more direct functional assays, such as the fibroblast collagen-synthesis measurements described above, before drawing mechanistic conclusions.
What does the copper coordination chemistry have to do with collagen research?
Several enzymes involved in collagen cross-linking and matrix remodeling, including lysyl oxidase, are themselves copper-dependent. Researchers examining GHK-Cu's copper-exchange behavior have proposed this as one route by which the complex could influence the collagen and matrix pathways measured in the fibroblast and gene-array studies.
Has this research been done in humans?
The studies summarized here are cell-culture, biochemical, and animal wound-model work. This article describes laboratory research findings, not clinical evidence, and nothing here is guidance for use in any subject.
References
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6. PubMed 3169264.
- Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-8. PubMed 11121126.
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. PubMed 18644225.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PubMed 26236730.
- Pickart L. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci. 2017;7(2):20. PubMed 28212278.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PubMed 29986520.
Research use only. Homegrown Peptides products are for laboratory research and are not for human or animal use. Nothing in this article is medical advice.
